Lupin gets warning letter from USFDA for Goa, Indore units

The company upholds quality and compliance issues with utmost seriousness and remains fully committed to be compliant with cGMP quality standards across all the facilities.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news